No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
The Type I Hypersensitivity Drug market is a subset of the Immune Disorders Drugs market, focusing on drugs used to treat Type I hypersensitivity reactions. These reactions are caused by an overactive immune system, which leads to an allergic response. Type I hypersensitivity drugs are used to reduce the severity of the allergic response, and can be administered orally, intravenously, or topically. Common drugs used to treat Type I hypersensitivity reactions include antihistamines, corticosteroids, and immunosuppressants.
The Type I Hypersensitivity Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more
